Background
Could delivering radiotherapy during brain tumour surgery improve treatment outcomes and quality of life?
For people living with recurrent glioblastoma (GBM) or brain metastases, treatment decisions can be particularly challenging, especially when balancing the potential benefits of further treatment against its impact on everyday life.
Dr Ryan Matthew and Dr Louise Murray at the University of Leeds are exploring an approach called intraoperative radiotherapy (IORT), which involves delivering a targeted dose of radiotherapy directly to the area where a tumour has been removed, while the patient is still under anaesthetic.
However, more research is needed to understand whether it offers meaningful benefits and which patients might benefit most.
Who can get involved?
We are looking for:
- People living with a glioblastoma or brain metastasis
- Caregivers, family members and loved ones of someone affected by glioblastoma or brain metastasis (including those who are bereaved)
What will you do?
Join brainstrust for a small, relaxed online conversation exploring what matters most when considering new approaches to brain tumour treatment.
There are no right or wrong answers. We’re interested in your thoughts, experiences and questions, whether you’ve previously donated tissue for research or have never considered what happens to it.
Why is it important to be part of this conversation?
Understanding what matters most to patients and their families is essential when developing new approaches to brain tumour treatment.
Your contributions will help researchers explore where IORT might fit within existing treatment pathways, identify which patients could benefit most and ensure that future research focuses on outcomes that matter to people affected by brain tumours.
Please note that these workshops will take place online via Zoom. You’ll receive joining details after registering.
